Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Shuang
Observed names:
Y. Shuang,
Yuerong Shuang
Institution:
Jiangxi Provincial Cancer Hospital
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Jiangxi Provincial Cancer Hospital,
Second Hospital of Tianjin Medical University,
Tianjin Medical University
ORCID:
0009-0001-1867-173X
Observed ORCID:
0009-0001-1867-173X
OpenAlex ID:
A5113916375
Outcomes of radiofrequency ablation (RFA) and CO2 laser for early glottic cancer
2016
·
Yu Shuang
, Chao Li
, et al.
·
American Journal of Otolaryngology
·
16
Association between interferon gamma 13-CA-repeats polymorphism and metastasis of nasopharyngeal carcinoma in a population of Northern China.
2015
·
Kaifei Hao
, Zhaohui Yan
, et al.
·
Europe PMC (PubMed Central)
·
5
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study
2025
·
Keshu Zhou
, Huijing Wu
, et al.
·
Cancer Biology and Medicine
·
1
PDF
Golidocitinib in Treating Refractory or Relapsed Peripheral T‐cell Lymphoma: Primary Analysis of the Multinational Pivotal Study Results (jackpot8)
2023
·
W. Kim
, Q. Cai
, et al.
·
Hematological Oncology
·
1
PDF
Endoscopic Endonasal Surgery to Resect a Solitary Trigeminal Neurofibroma Involving the Infratemporal Fossa: A Case Report
2022
·
Pan-Pan Liu
, Xue-bing Liu
, et al.
·
Ear Nose & Throat Journal
·
1
Factors Which Affect Efficacy and Resistance of Immune-checkpoint Blockade on Cancer
2017
·
Yu Shuang
·
Zhongliu fangzhi yanjiu
·
1
827P Comparison of efficacy and safety between glofitamab and real-world regimens among Chinese patients with 3L+ relapsed/refractory diffuse large B-cell lymphoma: An external control study
2024
·
K. Zhou
, H. Wu
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
7
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type